Dominic Clarke, PhD

Latest from Dominic Clarke, PhD

Cryopreserved Leukapheresis Materials Help Alleviate Donor Sourcing Issues logo in a gray background |
Biochemicals/Raw Materials
Cryopreserved Leukapheresis Materials Help Alleviate Donor Sourcing IssuesCryopreserved Leukapheresis Materials Help Alleviate Donor Sourcing Issues
byBrad Taylor, Dominic Clarke, PhD
Dec 6, 2020
The Cell Therapy Industry Needs High-Quality Healthy-Donor Material
Cell Therapies
The Cell Therapy Industry Needs High-Quality Healthy-Donor MaterialThe Cell Therapy Industry Needs High-Quality Healthy-Donor Material
byBrad Taylor, Dominic Clarke, PhD
Dec 4, 2019

All from Dominic Clarke, PhD

Development of a Novel Cold Chain Tubing, FP-FLEX™, and Single- Use Freezing Bag for Working Cell Banks Enabling Closed-System Processing to
Sponsored Content
Development of a Novel Cold Chain Tubing, FP-FLEX™, and Single- Use Freezing Bag for Working Cell Banks Enabling Closed-System Processing to Temperatures as Low as -196°C
Development of a Novel Cold Chain Tubing, FP-FLEX™, and Single- Use Freezing Bag for Working Cell Banks Enabling Closed-System Processing to Temperatures as Low as -196°C
Nov 17, 2015
|
1 Min Read
+1
byDominic Clarke, PhD, Bradley Bennettand 1 more
Development of a Novel Cold-Chain Tubing, FP-FLEX™, and Single-Use Freezing Bag: For Working Cell Banks Enabling Closed-System Processing to
Sponsored Content
Development of a Novel Cold-Chain Tubing, FP-FLEX™, and Single-Use Freezing Bag: For Working Cell Banks Enabling Closed-System Processing to Temperatures As Low As –196 °C
Development of a Novel Cold-Chain Tubing, FP-FLEX™, and Single-Use Freezing Bag: For Working Cell Banks Enabling Closed-System Processing to Temperatures As Low As –196 °C
Aug 19, 2015
|
1 Min Read
byDominic Clarke, PhD
Freeze-Pak™ STS Biocontainers and STS Shippers: Offering a New Single-Use Solution for Frozen Storage and Transport to -80 °C
Sponsored Content
Freeze-Pak™ STS Biocontainers and STS Shippers: Offering a New Single-Use Solution for Frozen Storage and Transport to -80 °C
Freeze-Pak™ STS Biocontainers and STS Shippers: Offering a New Single-Use Solution for Frozen Storage and Transport to -80 °C
Aug 15, 2014
byDominic Clarke, PhD, Brad Bennett
Validation of the New Single-Use Freeze-Pak™STS logo in a gray background | Validation of the New Single-Use Freeze-Pak™STS
Single Use
Validation of the New Single-Use Freeze-Pak™STS
Validation of the New Single-Use Freeze-Pak™STS
Aug 1, 2013
byDominic Clarke, PhD, Jared Ragone
Single-Use Technologies in Cell Therapy logo in a gray background | Single-Use Technologies in Cell Therapy
Contract Services
Single-Use Technologies in Cell Therapy
Single-Use Technologies in Cell Therapy
Mar 1, 2013
byDominic Clarke, PhD
Establishing Strategic Supplier Partnerships to Facilitate Manufacturing Success logo in a gray background | Establishing Strategic Supplier Partnerships to Facilitate Manufacturing Success
MAb
Establishing Strategic Supplier Partnerships to Facilitate Manufacturing Success
Establishing Strategic Supplier Partnerships to Facilitate Manufacturing Success
Dec 1, 2012
+2
byRobert Large, Jared Ragoneand 2 more
New EXP-Pak™ Closed-System Disposable Cell Expansion Bags logo in a gray background | New EXP-Pak™ Closed-System Disposable Cell Expansion Bags
Cell Culture Media
New EXP-Pak™ Closed-System Disposable Cell Expansion Bags
New EXP-Pak™ Closed-System Disposable Cell Expansion Bags
Aug 1, 2012
+1
byDominic Clarke, PhD, Sabine Ellwangerand 1 more
Implementing Custom Single-Use Solutions for Cell Therapy Production logo in a gray background | Implementing Custom Single-Use Solutions for Cell Therapy Production
MAb
Implementing Custom Single-Use Solutions for Cell Therapy Production
Implementing Custom Single-Use Solutions for Cell Therapy Production
May 1, 2012
byDominic Clarke, PhD
Cryogenic Storage of Human Hematopoietic Progenitor Cells logo in a gray background | Cryogenic Storage of Human Hematopoietic Progenitor Cells
Business
Cryogenic Storage of Human Hematopoietic Progenitor Cells
Cryogenic Storage of Human Hematopoietic Progenitor Cells
Aug 1, 2011
byDominic Clarke, PhD

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Ask the Expert webcasts
ATE Webcasts
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Ask the Expert webcasts
ATE Webcasts
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Insider News
See all
Dec 2 - Dec 5, 2024
The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success
Learn More

Innovative Technology

Emerson white paper
Sponsored Content
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency

Nov 12, 2024

WuXi Bio white paper
Sponsored Content
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products

Nov 8, 2024

Bora white paper
Sponsored Content
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages

Nov 8, 2024